Certified by Founder Lodge
Allorion Therapeutics
United States - Natick, Massachusetts
START UP
1 Disclosed Funding Rounds $50,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Allorion Therapeutics, we focus on developing novel small molecule drugs against cancer and autoimmune diseases. Our team is comprised of experts in cancer biology and drug development. Th
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 13 ,2023 | Series B | $50,000,000 |
Qiming Venture Partners USA
Octagon Capital Srl
3SBio Inc.
Long River Investment Management Limited
INCE Capital
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Bitreport | $316,823 | (Nov 19, 2024)
SuperAnnotate | $36,000,000 | (Nov 19, 2024)
Plantible | $30,000,000 | (Nov 19, 2024)
ANELLO Photonics | Undisclosed Amount | (Nov 19, 2024)
Bluespine | $7,200,000 | (Nov 19, 2024)
